Figueroa HMF, Castillo RJM, Signoret BMT, Macedo PM, Berumen GC, Vega MME

Language: Spanish
References: 17
Page: 162-164
PDF size: 169.51 Kb.

ABSTRACT

Perforating dermatoses (PD) are a heterogeneous group of skin disorders characterized by the transepidermal elimination of abnormal dermal components, such as collagen fibers, elastin, or cellular debris. This phenomenon can be observed in various conditions, many of which are chronic-degenerative in nature. We present the case of a patient with disseminated dermatosis affecting all body segments, predominantly the lumbar region, with a history of systemic arterial hypertension, type 2 diabetes, and chronic kidney disease. The patient suddenly developed gait lateralization, leading to a lumbar puncture and the diagnosis of Cryptococcus neoformans meningitis.

REFERENCES

1. Wagner G y Sachse MM, Acquired reactive perforating dermatosis,J Dtsch Dermatol Ges 2013; 11(8):723-30.

2. González-Lara L, Gómez-Bernal S, Vázquez-López F y Vivanco-Allende B, Dermatosis perforante adquirida: presentación de 8casos, Actas Dermo-Sifiliograficas 2014; 105(6):e39-43.

3. Rapini RP, Herbert AA y Drucker CR. Acquired perforating dermatosis,Arch Dermatol 1989; 125:1074-8.

4. Roldán-Contreras SE, Mendoza Martínez JR, Marín-HernándezE y Coronado-Malagón M, Acquired perforating dermatosis anddermatology life quality index in patients receiving hemodialysis,Nefrologia 2024; 44(2):251-5.

5. Karpouzis A, Giatromanolaki A, Sivridis E y Kouskoukis C, Acquiredreactive perforating collagenosis: current status, J Dermatol2010; 37(7):585-92.

6. Vengoechea-Guerrero AE, Hermosillo Cardoza BA, Dufflart-Ocampo JD, Palacios-Narváez DC, Cantú-Maltos HA, Sáenz-CorralC y Vega-Memije ME, Dermatosis perforante adquirida y calcifilaxiscoexistente, Dermatol Rev Mex 2023; 67(1):90-4.

7. Rapini RP, Perforating diseases. En Bologna J, Jorizzo J y RapiniR, Dermatology, Londres, Elsevier, 2008, pp. 1461-7.

8. Faver IR, Daoud MS y Su WP, Acquired reactive perforating collagenosis.Report of six cases and review of the literature, J AmAcad Dermatol 1994; 30:575-80.

9. Karpouzis A, Giatromanolaki A, Sivridis E y Kouskoukis C. Acquiredreactive perforating collagenosis: current status, J Dermatol2010; 37:585-92.

10. Gómez ML, Busso SP, Santoro G y Cabrera HN, Manifestacionescutáneas en pacientes hemodializados. A propósito de 150casos. Análisis casuístico, Arch Argent Dermatol 1995; 45:3-10.

11. Carter VH y Constantine VS, Kyrlie’s disease: clinical findingsin five cases and review of the literature, Arch Dermatol 1968;97:624-32.

12. Patterson JW y Brown PC, Ultraestructural changes in acquiredperforating dermatosis, Int J Dermatol 1992; 31:201-5.

13. Arias M, La Forgia M, Buonsante ME, Portaluppi M, Kien MC yPellerano G, Dermatosis perforante adquirida en pacientes coninsuficiencia renal crónica. Comunicación de tres casos y revisiónde la literatura, Dermatol Argent 2007; 13;184-9.

14. Karpouzis A, Giatromanolaki A, Sivridis E y Kouskoukis C, Acquiredreactive perforating collagenosis: current status, J Dermatol2010; 37:585-92.

15. Barrezueta-Chea S, Luis-Montoya P y Vega-Memije ME, Elastosisperforante serpiginosa: reporte de un caso asociado consíndrome de Down y revisión de la bibliografía, DermatologíaRev Mex 2005; 49:211-4.

16. Saray Y, Seçkin D y Bilezikçi B, Acquired perforating dermatosis:clinicopathological features in twenty-two cases, jeadv 2006;20:679-88.

17. Kim SW, Kim MS, Lee JH, Son SJ, Park KY, Li K, Seo SJ y HanTY, A clinicopathologic study of thirty cases of acquired perforatingdermatosis in Korea, Ann Dermatol 2014; 26(2):162-71.